SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-000976
Filing Date
2023-05-10
Accepted
2023-05-10 16:33:58
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20230331x10q.htm   iXBRL 10-Q 1677123
2 EX-31.1 nwbo-20230331xex31d1.htm EX-31.1 10440
3 EX-32.1 nwbo-20230331xex32d1.htm EX-32.1 7428
  Complete submission text file 0001410578-23-000976.txt   8627215

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20230331.xsd EX-101.SCH 72048
5 EX-101.CAL nwbo-20230331_cal.xml EX-101.CAL 51749
6 EX-101.DEF nwbo-20230331_def.xml EX-101.DEF 317425
7 EX-101.LAB nwbo-20230331_lab.xml EX-101.LAB 476037
8 EX-101.PRE nwbo-20230331_pre.xml EX-101.PRE 435039
64 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20230331x10q_htm.xml XML 1736384
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 23907088
SIC: 2834 Pharmaceutical Preparations